|
|||
|
LABORATORY OF MOLECULAR GENETICS
|
|||
| Igor B. Dawid, Ph.D., Chief | |||
|
The Laboratory of Molecular Genetics (LMG) pursues studies in different
systems that aim to elucidate molecular-genetic mechanisms of physiological
and developmental control, in particular the regulation of signalling
and signal transduction cascades during development. Of note are the discoveries
made by the groups of two tenure-track investigators, both working on
the zebrafish, a premier vertebrate model system for the study of embryogenesis. The group of Brant Weinstein works on vascular biology, specifically
the mechanisms of vasculogenesis, the initial generation of blood vessels
in the embryo, and the molecular-genetic distinctions that define arterial
and venous identity. While functional redirection of veins to arteries
and vice versa can take place in the organism, recent work completed
by many groups, including this LMG group, indicates that there is a genetically
programmed distinction between different vessels when they first arise
in the embryo. Work by Dr. Weinstein and colleagues has illuminated the
signalling cascade that defines arterial identity in the embryo. By using
a combination of genetic, molecular, and embryological techniques, the
researchers showed that vascular endothelial growth factor (VEGF) plays
a major role in embryonic arterial development. VEGF is expressed under
the control of hedgehog signalling in the embryo and, in turn, regulates
the activity of Notch that gives the proximal signal leading to vessels
with arterial identity. Identification of the contribution of Notch signalling to vessel formation relied in part on the use of a mutation, mindbomb (mib), in which too many primary neurons are generated in the embryo as a result of deficits in the Notch signalling cascade. Ajay Chitniss group discovered and has studied this mutant. Notch is a signalling system of major importance in many developmental systems and plays a role in some human tumors. Dr. Chitnis and his colleagues have shown that the mib mutation disrupts a gene that encodes a so-called E3 ligase. E3 ligases are the specificity-endowing components of the ubiquitin-dependent protein modification and degradation machinery, and the mib gene product functions specifically in the Notch pathway. Chitnis and colleagues work represents a major advance in expanding our understanding of the important and much-studied Notch pathway and, as such, has far-reaching implications in biology. |
|||